Cinchona Pubescens Whole
Generic Name: cinchona pubescens whole
Dosage form: LIQUID. Active ingredients: CINCHONA PUBESCENS WHOLE (1 [hp_X]/mL). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: LIQUID. Active ingredients: CINCHONA PUBESCENS WHOLE (1 [hp_X]/mL). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as liquid.
Related Medications
Aluminum Oxide, Silver, Silver Nitrate, Arsenic Trioxide, Mercurius Solubilis, Calomel, Mercuric Iodide, Lead, Lead Iodide, Chelidonium Majus, Zinc, Solidago Virgaurea Flowering Top, And Citric Acid Monohydrate
aluminum oxide, silver, silver nitrate, arsenic trioxide, mercurius solubilis, calomel, mercuric iodide, lead, lead iodide, chelidonium majus, zinc, solidago virgaurea flowering top, and citric acid monohydrate
Heavy metal detox.
Coccidioides Immitis Spherule-derived Skin Test Antigen
coccidioides immitis spherule-derived skin test antigen
Skin Test Antigen [EPC]
11 DESCRIPTION Spherusol ® is a sterile aqueous solution of extracts of C. immitis spherules. The multi-dose vial contains 0.9% sodium chloride and 0.014% sodium borate with 0.4% phenol as a preservative. Residual thimerosal from the manufacturing process is present at a concentration of ≤0.0001% (<0.05 mcg mercury/0.1 mL dose). Each 0.1 mL dose contains 1.27 mcg of spherule-derived antigen. The potency of each lot of Spherusol ® is determined in sensitized guinea pigs.
Patritumab Deruxtecan
patritumab deruxtecan
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION. Active ingredients: PATRITUMAB DERUXTECAN (100 mg/5mL). Category: DRUG FOR FURTHER PROCESSING.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.